<PAGE>
Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
November 20, 2000
IMX PHARMACEUTICALS, INC.
(Exact name of Registrant as specified in its charter)
Commission File Number 000-30294
Utah 87-0394290
------------------------------- -------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization Identification No.)
2295 Corporate Boulevard, Suite 131, Boca Raton, Florida 33431
(Address of Principal Executive Offices)
561-998-5660
(Registrant's Telephone number, including area code)
<PAGE>
ITEM 3. Bankruptcy or Receivership.
On November 20, 2000, IMX Pharmaceuticals, Inc. and its wholly-owned
subsidiary, IMX ETI LifePartners, Inc. filed voluntary petitions for relief
under Chapter 11 of the United States Bankruptcy Code in the United States
Bankruptcy Court for the Southern District of Florida, West Palm Beach Division.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant duly caused this report to be signed on its behalf by the
undersigned hereto duly authorized.
IMX PHARMACEUTICALS, INC.
By: /s/ WILLIAM A. FORSTER
-----------------------------
William A. Forster, President
Dated: November 21, 2000
2
